The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study
Open accessAbstract
Objective To examine whether past high sun exposure is associated with a reduced risk of multiple sclerosis. Design Population based case-control study. Setting Tasmania, latitudes 41-3°S. Participants 136 cases with multiple sclerosis and 272 controls randomly drawn from the community and matched on sex and year of birth. Main outcome measure Multiple sclerosis defined by both clinical and magnetic resonance imaging criteria. Results Higher sun exposure when aged 6-15 years (average 2-3 hours or more a day in summer during weekends and holidays) was associated with a decreased risk of multiple sclerosis (adjusted odds ratio 0.31, 95% confidence interval 0.16 to 0.59). Higher exposure in winter seemed more important than higher exposure in summer. Greater actinic damage was also independently associated with a decreased risk of multiple sclerosis (0.32, 0.11 to 0.88 for grades 4-6 disease). A dose-response relation was observed between multiple sclerosis and decreasing sun exposure when aged 6-15 years and with actinic damage. Conclusion Higher sun exposure during childhood and early adolescence is associated with a reduced risk of multiple sclerosis. Insufficient ultraviolet radiation may therefore influence the development of multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study
Hyppönen, E., Läärä, E., Reunanen, A., Järvelin, M.-R., & Virtanen, S. M. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06580-1 · Cited by 1,928
WEINSHENKER, B. G., BASS, B., RICE, G. P. A., NOSEWORTHY, J., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1989) · Brain · doi:10.1093/brain/112.1.133 · Cited by 1,452
The evolution of human skin coloration
Jablonski, N. G., & Chaplin, G. (2000) · Journal of Human Evolution · doi:10.1006/jhev.2000.0403 · Cited by 1,212
Cantorna, M. T., Hayes, C. E., & DeLuca, H. F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7861 · Cited by 718
The prevalence of multiple sclerosis in the world: an update
Rosati, G. (2001) · Neurological Sciences · doi:10.1007/s100720170011 · Cited by 656
Paty, D. W., Oger, J. J. F., Kastrukoff, L. F., Hashimoto, S. A., Hooge, J. P., Eisen, A. A., Eisen, K. A., Purves, S. J., Low, M. D., Brandejs, V., et al. (1988) · Neurology · doi:10.1212/wnl.38.2.180 · Cited by 639
Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level
Vieth, R., Chan, P.-C. R., & MacFarlane, G. D. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.288 · Cited by 616
Acheson, E. D., Bachrach, C. A., & Wright, F. M. (1960) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1960.tb08674.x · Cited by 277
Cantorna, M. T., Woodward, W. D., Hayes, C. E., & DeLuca, H. F. (1998) · PubMed · Cited by 257
Hammond, S. R. (2000) · Brain · doi:10.1093/brain/123.5.968 · Cited by 228
van der Mei, I. A. F., Ponsonby, A.-L., Blizzard, L., & Dwyer, T. (2001) · Neuroepidemiology · doi:10.1159/000054783 · Cited by 216
Self-citationTHE EPIDEMIOLOGY OF MULTIPLE SCLEROSIS IN THREE AUSTRALIAN CITIES: PERTH, NEWCASTLE AND HOBART
HAMMOND, S. R., MCLEOD, J. G., MILLINGEN, K. S., STEWART-WYNNE, E. G., ENGLISH, D., HOLLAND, J. T., & MCCALL, M. G. (1988) · Brain · doi:10.1093/brain/111.1.1 · Cited by 211
Goldberg, P., Fleming, M. C., & Picard, E. H. (1986) · Medical Hypotheses · doi:10.1016/0306-9877(86)90010-1 · Cited by 200
Vitamin D: a natural inhibitor of multiple sclerosis
Hayes, C. E. (2000) · Proceedings of the Nutrition Society · doi:10.1017/s0029665100000768 · Cited by 180
Freedman, D. M., Dosemeci, M., & Alavanja, M. C. R. (2000) · Occupational and Environmental Medicine · doi:10.1136/oem.57.6.418 · Cited by 168
Pathogenesis of multiple sclerosis: an update on immunology
Hemmer, B., Cepok, S., Nessler, S., & Sommer, N. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200206000-00001 · Cited by 139
The Geographic Distribution of Multiple Sclerosis: A Review
Ebers, G. C., & Sadovnick, A. D. (1993) · Neuroepidemiology · doi:10.1159/000110293 · Cited by 126
Reproducibility of reported measurements of sun exposure in a case-control study.
English, D. R., Armstrong, B. K., & Kricker, A. (1998) · PubMed · Cited by 104
Does Immunosuppressive Ultraviolet Radiation Explain the Latitude Gradient for Multiple Sclerosis?
McMichael, A. J., & Hall, A. J. (1997) · Epidemiology · doi:10.1097/00001648-199710000-00005 · Cited by 102
Rubio, J. P., Bahlo, M., Butzkueven, H., van der Mei, I. A. F., Sale, M. M., Dickinson, J. L., Groom, P., Johnson, L., Simmons, R. D., Tait, B. D., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339932 · Cited by 94
Self-citationDwyer, T., Blizzard, L., Gies, P. H., Ashbolt, R. H., & Roy, C. R. (1996) · Melanoma Research · doi:10.1097/00008390-199606000-00006 · Cited by 72
Self-citationDwyer, T. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.7.614 · Cited by 62
Self-citationHauser, S. L., Weiner, H. L., Che, M., SHAPIRO, M. E., Gilles, F. H., & Letvin, N. L. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.3.1276 · Cited by 57
The use of spectrophotometry to estimate melanin density in Caucasians
Dwyer, T., Muller, K., Blizzard, L., Ashbolt, R. H., & Phillips, G. W. M. (1997) · Melanoma Research · doi:10.1097/00008390-199706001-00245 · Cited by 50
Self-citationThe prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist?
Forbes, R. B., Wilson, S. V., & Swingler, R. J. (1999) · Journal of Neurology · doi:10.1007/s004150050509 · Cited by 49
Premature ageing of the skin in a Queensland population
Green, A. C. (1991) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1991.tb93845.x · Cited by 47
Effects of Ultraviolet Exposure on the Immune System
Garssen, J., & Loveren, H. V. (2001) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v21.i4.40 · Cited by 45
Holman, C. D. J., EVANS, P. R., LUMSDEN, G. J., & Armstrong, B. K. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113906 · Cited by 42
Hillert, J. A., & Olerup, O. (1993) · Neurology · doi:10.1212/wnl.43.11.2426-a · Cited by 25
Fritschi, L., & Green, A. C. (1995) · Australian Journal of Public Health · doi:10.1111/j.1753-6405.1995.tb00390.x · Cited by 13
Khan (2000) · doi:10.1002/1531-8249(200008)48:2
Cited by
Holick, M. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1678s · Cited by 3,198
High Prevalence of Vitamin D Inadequacy and Implications for Health
Holick, M. F. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.3.353 · Cited by 2,005
Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006) · JAMA · doi:10.1001/jama.296.23.2832 · Cited by 1,897
Gender differences in autoimmune disease
Ngo, S. T., Steyn, F. J., & McCombe, P. A. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.04.004 · Cited by 1,074
Melatonin: Buffering the Immune System
Carrillo-Vico, A., Lardone, P., Álvarez-Sánchez, N., Rodríguez-Rodríguez, A., & Guerrero, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14048638 · Cited by 740
Metadata
- Authors
- van der Mei, I. A. F., Ponsonby, A.-L., Dwyer, T., Blizzard, L., Simmons, R., Taylor, B. V., Butzkueven, H., & Kilpatrick, T.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2003-08-07
- Volume
- 327
- Issue
- 7410
- Pages
- 316
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2132499228
- Cited by
- 551
- References
- 32
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.